Felipe Vences-Catalán
Mountain View, California, United States
269 followers
266 connections
About
I am a highly motivated biomedical scientist with 15+ years of academic research…
Activity
-
Dr. Miguel E. Moreno-Garcia, Director of Research at SENS Research Foundation, was invited to share the latest developments from the SRF Research lab…
Dr. Miguel E. Moreno-Garcia, Director of Research at SENS Research Foundation, was invited to share the latest developments from the SRF Research lab…
Liked by Felipe Vences-Catalán
-
Great opportunity to join the team!
Great opportunity to join the team!
Liked by Felipe Vences-Catalán
-
More than 50 Stanford Biosciences graduate students and postdocs connected with representatives from Amgen this past week and gained insights into…
More than 50 Stanford Biosciences graduate students and postdocs connected with representatives from Amgen this past week and gained insights into…
Liked by Felipe Vences-Catalán
Experience
Education
-
CINVESTAV
-
-
-
-
-
Publications
-
A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression
-
Felipe Vences-Catalán*, Chiung-Chi Kuo*, Yael Sagi*, Homer Chen*, Neta Kela-Madar*, Menno C. van Zelm†, Jacques J. M. van Dongen† and Shoshana Levy*.
Accepted
Journal of Clinical Immunology -
CD38 through the life of a murine B lymphocyte
-
Vences-Catalan, F., and Santos-Argumedo, L. (2011) IUBMB Life 63, 840-846.
-
Consequences of two naturally occurring missense mutations in the structure and function of Bruton agammaglobulinemia tyrosine kinase
-
Vargas-Hernandez, A., Lopez-Herrera, G., Maravillas-Montero, J. L., Vences-Catalan, F., Mogica-Martinez, D., Rojo-Dominguez, A., Espinosa-Rosales, F. J., and Santos-Argumedo, L. (2012) IUBMB Life 64, 346-353.
-
Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein
-
Al Olaby RR, Cocquerel L, Zemla A, Saas L, Dubuisson J, Vielmetter J, Vences-Catalan F et al. . PLoS One. 2014;9(10):e111333.
-
Role of an arginine-lysine rich motif in maturation and trafficking of CD19.
Vences-Catalán F1, Kuo CC1, Levy S2.Biochem Biophys Res Commun. 2015 Sep 25;465(3):319-23
-
Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells.
Vences-Catalan F, Rajapaksa R, Srivastava MK, Marabelle A, Kuo CC, Levy R, Levy S. Cancer Res. 2015 Sep 1
-
The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes
-
Vences-Catalan, F., Rajapaksa, R., Levy, S., and Santos-Argumedo, L. (2012) , Immunology 137, 48-55.
-
TSPAN33 is a novel marker of activated and malignant B cells
-
Luu, V. P., Hevezi, P., Vences-Catalan, F., Maravillas-Montero, J. L., White, C. A., Casali, P., Llorente, L., Jakez-Ocampo, J., Lima, G., Vilches-Cisneros, N., Flores-Gutierrez, J. P., Santos-Argumedo, L., and Zlotnik, A. (2013) , Clin Immunol 149, 388-399.
Patents
-
Humanized and chimeric monoclonal antibodies to cd81
US WO2017218691A1
Humanized or chimeric anti-CD81 (cluster of differentiation 81) monoclonal antibodies are provided. The antibodies bind to human CD81, and find use in various therapeutic methods, including without limitation the reduction or prevention of tumor metastasis. Further provided are heavy chain and light chain variable region sequences as well as associated complementarity-determining region (CDR) sequences.
Honors & Awards
-
Fundacion TELMEX
-
2008-2012
-
M.S. Fellowship
-
2006-2008
CONACyT -
PhD Fellowship
-
2008-2012
CONACyT
Languages
-
Español
Native or bilingual proficiency
-
Inglés
Full professional proficiency
More activity by Felipe
-
We are hiring! Position #2. Join a great team of In Vivo Pharmacologists at Amgen Inflammation Research! Do great science, develop the next…
We are hiring! Position #2. Join a great team of In Vivo Pharmacologists at Amgen Inflammation Research! Do great science, develop the next…
Liked by Felipe Vences-Catalán
-
A postdoctoral training opportunity in membrane protein structure and function (lysosome biology)
A postdoctoral training opportunity in membrane protein structure and function (lysosome biology)
Liked by Felipe Vences-Catalán
-
We are hiring! Join our team at Amgen - Inflammation Research, In Vivo Pharmacology. A great opportunity to start or continue your career in a…
We are hiring! Join our team at Amgen - Inflammation Research, In Vivo Pharmacology. A great opportunity to start or continue your career in a…
Liked by Felipe Vences-Catalán
-
Tras la visita de investigadores de Georgia Tech y Worcester Polytechnic Institute a nuestra Facultad de Ciencias Agronómicas (FCA) y a nuestra…
Tras la visita de investigadores de Georgia Tech y Worcester Polytechnic Institute a nuestra Facultad de Ciencias Agronómicas (FCA) y a nuestra…
Liked by Felipe Vences-Catalán
-
🎉 Thank You for Making Gene-Ius Break in San Francisco an Amazing Experience! 🎉 We’re thrilled with the success of our Gene-Ius Break event in SF!…
🎉 Thank You for Making Gene-Ius Break in San Francisco an Amazing Experience! 🎉 We’re thrilled with the success of our Gene-Ius Break event in SF!…
Liked by Felipe Vences-Catalán
-
Today, we celebrate the spectacular Amgen career of Discovery Research SVP Ray Deshaies, Ph.D. who recently shared his plans to retire. Ray joined…
Today, we celebrate the spectacular Amgen career of Discovery Research SVP Ray Deshaies, Ph.D. who recently shared his plans to retire. Ray joined…
Liked by Felipe Vences-Catalán
-
Today, I officially handed off the role of interim head of Research at Amgen to Angela Coxon, who I have had the privilege of having served under me…
Today, I officially handed off the role of interim head of Research at Amgen to Angela Coxon, who I have had the privilege of having served under me…
Liked by Felipe Vences-Catalán
-
I'm excited to announce some recent milestones in my career journey: 🎓 Recently graduated with a PhD from Purdue University. 📝 Published part of…
I'm excited to announce some recent milestones in my career journey: 🎓 Recently graduated with a PhD from Purdue University. 📝 Published part of…
Liked by Felipe Vences-Catalán
-
A Stanford Medicine trial of CAR-T cell therapy for high-risk lymphoma was awarded FDA breakthrough designation. Early results show promise for those…
A Stanford Medicine trial of CAR-T cell therapy for high-risk lymphoma was awarded FDA breakthrough designation. Early results show promise for those…
Liked by Felipe Vences-Catalán
-
Thank you Uduak Grace Thomas for the interview and new article in Genetic Engineering & Biotechnology News! Uduak's article dives deeper into the…
Thank you Uduak Grace Thomas for the interview and new article in Genetic Engineering & Biotechnology News! Uduak's article dives deeper into the…
Liked by Felipe Vences-Catalán
-
Great speaking with Kyle LaHucik about all things TwoStep Therapeutics. Read more about our next stage of growth in Endpoints…
Great speaking with Kyle LaHucik about all things TwoStep Therapeutics. Read more about our next stage of growth in Endpoints…
Liked by Felipe Vences-Catalán
-
Muy orgullosos de haber participado en la “16ª Carrera Aquí Nadie se Rinde” con salida y meta en el Estadio Olímpico de Ciudad Universitaria. Desde…
Muy orgullosos de haber participado en la “16ª Carrera Aquí Nadie se Rinde” con salida y meta en el Estadio Olímpico de Ciudad Universitaria. Desde…
Liked by Felipe Vences-Catalán
-
Thrilled to share that TwoStep Therapeutics has officially launched! With the closing of our seed round, we’ll be advancing our pipeline of targeted…
Thrilled to share that TwoStep Therapeutics has officially launched! With the closing of our seed round, we’ll be advancing our pipeline of targeted…
Liked by Felipe Vences-Catalán
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More